Confident selection and optimization of lead compounds during drug discovery – label-free screening and characterization
Reduce costs in biotherapeutic development – early kinetic screening of hybridomas for mAb selection
Optimize safety and efficacy – define serum antibody responses in immunogenicity studies and immunotherapeutic development
Perform large scale functionality studies – high quality, high information-content interaction studies in proteomics
Optional packages with additional software functionality
To download the pdf's below, please enter your login details. If you do not have a Biacore website account yet, you can sign up here.
Take the Biacore A100 Quick Tour (Requires Flash Player 8)
Choose your destination
